The t:slim G4 Pump is for use by people 12 years of age or older who use insulin. Tandem previously announced FDA approval of the product on September 9, 2015.

The t:slim G4 System combines features of the t:slim Insulin Pump and the Dexcom G4 PLATINUM CGM System, devices that have consistently ranked #1 in independent user surveys.

The t:slim G4 Pump is the newest addition to the Company’s family of products, which includes the t:slim and t:flex Insulin Pumps.

Each pump features a touch screen with a streamlined, user-friendly interface. This provides people rapid access to frequently used features while eliminating the need for excessive scrolling and button pressing, making these features simple to learn and simple to use.

Each Tandem product utilizes modern technology, such as a built-in rechargeable battery and a micro-USB port for convenient charging and fast data transfers. They also feature the Company’s Micro-Delivery technology that allows for basal delivery every 5 minutes in increments as small as 0.001 unit. The t:slim G4 and t:slim Pumps are the slimmest and smallest durable insulin pumps on the market, yet still hold up to 300 units of insulin.

The t:slim G4 Pump can operate as a stand-alone insulin pump or be paired with a Dexcom G4 PLATINUM sensor. When paired with the CGM sensor, the pump closely mimics the interface of the Dexcom system, tracking glucose continuously and displaying color-coded graphs and arrows directly on the Pump’s home screen to help users manage their diabetes.

The system also allows users to program personalized glucose targets, alerts, and alarms for when glucose levels rise or fall to dangerous levels.

Tandem Diabetes Care is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin.